Company Overview and News

2
China Brewer Gets Premium Brand in $3.1 Billion Heineken Tie-Up - Bloomberg

2018-08-03 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
ASBRY ASBRF BUD 0168 2502 AHBIF HEIA

0
China’s stock benchmark set for biggest monthly drop since aftermath of 2015 crash

2018-06-28 scmp
The Shanghai Composite Index is headed for its biggest monthly decline since a 23pc tumble in January 2016 amid fears of trade war and worsening liquidity
0168

0
Bourse chief confident Hong Kong will net world’s biggest IPO candidate Saudi Aramco

2018-06-21 scmp
HKEX chief executive Charles Li believes the oil giant will choose Hong Kong for its international listing despite the trade war threat rattling the local market
0168

0
Demand for beer froths ahead of 2018 World Cup

2018-06-12 business.inquirer.net
Beer is sold at a 2018 World Cup-themed promotion event at a supermarket in Nanjing, Jiangsu province, on June 7. [Photo by Yu Tian/For China Daily]
0168

4
China beer stock bulls pine for vindication on valuations

2018-06-06 thestar.com.my
While the sector lags behind global brewers in operating margins and earnings growth, the companies trade at a premium that outstrips their peer average by several times – thanks in part to the US-China trade tension that recently sparked a wave of demand for shares of domestically focused sectors from beverage to healthcare.
0168 MSCI

18
Investors in Chinese Brewing Stocks May Have Beer Goggles On - Bloomberg

2018-06-05 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BUD 0168 ABI AHBIF MSCI

0
PetroChina lifts Hong Kong stocks to biggest two-week gain on gas price increase

2018-05-28 scmp
China’s largest producer of oil and gas contributed to almost 13 per cent of the gain on the Hang Seng Index
0168 XNGSF CGASY XNGSY CHOLY 2883 CHOLF

4
UPDATE 1-Global investors pile into China stocks ahead of MSCI index entry

2018-04-27 reuters
SHANGHAI (Reuters) - Overseas investors are pumping billions of dollars into Chinese stocks and the country’s asset managers are rushing to launch index-tracking funds in a fervent build-up to China’s inclusion in MSCI’s widely tracked equity benchmarks.
0168 MSCI

4
Global investors pile into China stocks ahead of MSCI index entry

2018-04-27 reuters
SHANGHAI, April 27 (Reuters) - Overseas investors are pumping billions of dollars into Chinese stocks and the country’s asset managers are rushing to launch index-tracking funds in a fervent build-up to China’s inclusion in MSCI’s widely tracked equity benchmarks.
0168 MSCI

2
Fosun Lives Twice, But an MGM Raid Could Change That - Bloomberg

2018-04-04 bloomberg - 2
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
ASBRY MGMB ASBRF 0168 2502 WLFDY

1
Chinese conglomerate Fosun to invest 100b yuan in AI, biotech and fintech over next decade

2018-03-28 scmp - 1
Chinese conglomerate Fosun International is looking to invest in areas such as biotechnology, financial technology and artificial intelligence, according to its chairman, Guo Guangchang. This investment will amount to 20 billion yuan (US$3.2 billion) over the next three years, and 100 billion yuan over the next decade, according to Wang Qunbin, the company’s chief executive.
FOSUF 0168 FLLIY 0656 FOSUY

121
China Wants Its Tech Firms Back. Are CDRs the Answer? - Bloomberg

2018-03-14 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BABA 0168 NTES BIDU

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...